Establishment Labs Holdings Inc (ESTA)
38.56
-0.76
(-1.93%)
USD |
NASDAQ |
Nov 14, 10:39
Establishment Labs Holdings Debt to Equity Ratio: 5.942 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.942 |
| June 30, 2024 | 4.303 |
| March 31, 2024 | 3.377 |
| December 31, 2023 | 10.26 |
| September 30, 2023 | 6.079 |
| June 30, 2023 | 3.316 |
| March 31, 2023 | -11.17 |
| December 31, 2022 | -21.44 |
| September 30, 2022 | 97.56 |
| June 30, 2022 | 9.169 |
| March 31, 2022 | 1.097 |
| December 31, 2021 | 1.023 |
| September 30, 2021 | 0.834 |
| June 30, 2021 | 0.7382 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.6934 |
| December 31, 2020 | 0.6648 |
| September 30, 2020 | 0.6175 |
| June 30, 2020 | 0.5984 |
| March 31, 2020 | 0.5374 |
| December 31, 2019 | 1.215 |
| September 30, 2019 | 1.090 |
| June 30, 2019 | 0.4472 |
| March 31, 2019 | 0.38 |
| December 31, 2018 | 0.3212 |
| September 30, 2018 | 0.2791 |
| June 30, 2018 | 10.86 |
| March 31, 2018 | -2.843 |
| December 31, 2017 | -4.805 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-21.44
Minimum
Dec 2022
97.56
Maximum
Sep 2022
5.771
Average
1.060
Median
Debt to Equity Ratio Benchmarks
| Bristol-Myers Squibb Co | 2.902 |
| Cassava Sciences Inc | -- |
| Aytu BioPharma Inc | 0.5459 |
| enVVeno Medical Corp | -- |
| Onconetix Inc | -0.4216 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 282.68M |
| Total Liabilities (Quarterly) | 249.98M |
| Shareholders Equity (Quarterly) | 32.71M |
| Current Ratio | 3.623 |
| Net Debt Paydown Yield | -0.20% |